ITW REAGENTS
ITW Reagents is fully integrated by AppliChem GmbH and PanReac Química SLU companies, under unique commercial brand PanReac AppliChem. The Division has two production plants in Spain and Germany.
With 75 years’ of experience, ITW Reagents is a Chemical producer of high quality chemicals for pharmaceutical manufacturing processes.
One of these processes is the pH adjustment in pharmaceutical production. In this process it is important to use reagents of the appropriate quality grade. Laboratory products are not suitable for this particular application as some important certificates requested by authorities will be missing.
Main advantages of PanReac AppliChem products:
- Acids and bases at different concentrations for different applications.
- Pharma grade: specifications according to main pharmacopoeias (USP and Ph. Eur.).
- Documents and certificates that regulatory bodies require: BSE / TSE, GMO, residual solvents, allergens, trace metal residues, etc.
- Different pack sizes are available to adjust your particular needs.
For further information contact us at customerservice.es@itwreagents.com
Contact Details:
Company name: ITW REAGENTS
Website:www.itwreagents.comE-mail: customerservice.es@itwreagents.com
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
